Amitriptyline for fibromyalgia: Off-label treatment, but non-inferior to approved medication
- PMID: 37002904
- DOI: 10.1111/1756-185X.14618
Amitriptyline for fibromyalgia: Off-label treatment, but non-inferior to approved medication
Comment on
-
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.JAMA Netw Open. 2022 May 2;5(5):e2212939. doi: 10.1001/jamanetworkopen.2022.12939. JAMA Netw Open. 2022. PMID: 35587348 Free PMC article.
References
REFERENCES
-
- Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. doi:10.1007/s11916-013-0356-5
-
- Ma KS, Lai JN, Veeravalli JJ, Chiu LT, Van Dyke TE, Wei JC. Fibromyalgia and periodontitis: bidirectional associations in population-based 15-year retrospective cohorts. J Periodontol. 2022;93(6):877-887. doi:10.1002/jper.21-0256
-
- Gau SY, Leong PY, Lin CL, Tsou HK, Wei JC. Higher risk for Sjögren's syndrome in patients with fibromyalgia: a nationwide population-based cohort study. Front Immunol. 2021;12:640618. doi:10.3389/fimmu.2021.640618
-
- Gau SY, Lee YH, Tsou HK, et al. Patients with ankylosing spondylitis are associated with high risk of fibromyalgia: a nationwide population-based cohort study. Front Med (Lausanne). 2021;8:618594. doi:10.3389/fmed.2021.618594
-
- Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi:10.1136/annrheumdis-2016-209724
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources